BofA raised the firm’s price target on Colgate-Palmolive (CL) to $105 from $100 and keeps a Buy rating on the shares. Friday’s presentation at CAGNY focused on its initiatives with its 2030 Strategic Plan, notes the analyst, who is raising the firm’s target to reflect increased conviction in business momentum and the company-specific action plan on innovation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive: Reaccelerating Growth from Pet Nutrition, Emerging Markets, and Innovation Makes CL a Preferred Buy
- Colgate-Palmolive price target raised to $100 from $94 at Goldman Sachs
- TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
- Colgate-Palmolive price target raised to $100 from $94 at Wells Fargo
- Colgate-Palmolive target raised to $93 from $84 at Rothschild & Co Redburn